(Q39122192)

9 September 2017

title

Methylation status and overexpression of COX-2 in Tunisian patients with ductal invasive breast carcinoma (English)

1 reference

9 September 2017

1 reference

Sondes Karray-Chouayekh

1

1 reference

9 September 2017

Fatma Trifa

2

1 reference

9 September 2017

Abdelmajid Khabir

3

1 reference

9 September 2017

Noureddine Boujelbene

4

1 reference

9 September 2017

Tahia Sellami-Boudawara

5

1 reference

9 September 2017

Jamel Daoud

6

1 reference

9 September 2017

Mounir Frikha

7

1 reference

9 September 2017

Ali Gargouri

8

1 reference

9 September 2017

Raja Mokdad-Gargouri

9

1 reference

9 September 2017

publication date

10 December 2010

1 reference

9 September 2017

1 reference

9 September 2017

volume

32

1 reference

9 September 2017

issue

3

1 reference

9 September 2017

page(s)

461-468

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-010-0139-0

9 September 2017

exact match

0 references

cites work

The lifetime risk of developing breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Molecular prognostic factors for breast cancer metastasis and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

HER2 as a prognostic factor in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Cyclooxygenase-2: a target for the prevention and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

The role of cyclooxygenase-2 in breast cancer: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Infrequent COX-2 expression due to promoter hypermethylation in gastric cancers in Dalian, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

DNA methylation patterns and epigenetic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Aberrant methylation of cyclooxygenase-2 in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Promoter methylation regulates cyclooxygenase expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

COX-2 induces IL-11 production in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogen-activated protein kinase (ERK1/2, p38) activation or with Her-2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0139-0

Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status

21 January 2018

1 reference

12 December 2020

Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

1 reference

12 December 2020

Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study

1 reference

12 December 2020

Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis

1 reference

12 December 2020

Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors

1 reference

12 December 2020

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer

1 reference

12 December 2020

Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.

1 reference

12 December 2020

The fundamental role of epigenetic events in cancer

1 reference

12 December 2020

10.1007/S13277-010-0139-0

Identifiers

DOI

1 reference

9 September 2017

1 reference